技术支持Technical Support
联系我们CONTACT US
- 400-999-210024小时服务热线
普诺赛致力于为科研客户提供高品质的细胞及培养相关产品,产品范围涵盖原代细胞、细胞系、胎牛血清,完全培养基,及其他培养试剂。经过多年的坚持和努力,普诺赛已协助客户发表高分文献4000余篇,文献常见于Nature Biotechnology、Nature Nanotechnology、Advanced Materials、Materials Today等行业顶尖期刊。
-
D3S-001, a KRAS G12C inhibitor with rapid target engagement kinetics, overcomes nucleotide cycling and demonstrates robust preclinical and clinical activities (2024/05/08)
IF: 28.200- 作者:Jing Zhang, Sunmin Lim, Mira Yu
- 期刊: Cancer Discovery
- DOI:10.1158/2159-8290.CD-24-0006
- 引用产品: CL-0400
-
D3S-001, a KRAS G12C inhibitor with rapid target engagement kinetics, overcomes nucleotide cycling and demonstrates robust preclinical and clinical activities (2024/05/08)
IF: 28.200- 作者:Jing Zhang, Sunmin Lim, Mira Yu
- 期刊: Cancer Discovery
- DOI:10.1158/2159-8290.CD-24-0006
- 引用产品: CL-0042
-
D3S-001, a KRAS G12C inhibitor with rapid target engagement kinetics, overcomes nucleotide cycling and demonstrates robust preclinical and clinical activities (2024/05/08)
IF: 28.200- 作者:Jing Zhang, Sunmin Lim, Mira Yu
- 期刊: Cancer Discovery
- DOI:10.1158/2159-8290.CD-24-0006
- 引用产品: CL-0014
-
D3S-001, a KRAS G12C inhibitor with rapid target engagement kinetics, overcomes nucleotide cycling and demonstrates robust preclinical and clinical activities (2024/05/08)
IF: 28.200- 作者:Jing Zhang, Sunmin Lim, Mira Yu
- 期刊: Cancer Discovery
- DOI:10.1158/2159-8290.CD-24-0006
- 引用产品: CL-0097
-
D3S-001, a KRAS G12C inhibitor with rapid target engagement kinetics, overcomes nucleotide cycling and demonstrates robust preclinical and clinical activities (2024/05/08)
IF: 28.200- 作者:Jing Zhang, Sunmin Lim, Mira Yu
- 期刊: Cancer Discovery
- DOI:10.1158/2159-8290.CD-24-0006
- 引用产品: CL-0096
-
D3S-001, a KRAS G12C inhibitor with rapid target engagement kinetics, overcomes nucleotide cycling and demonstrates robust preclinical and clinical activities (2024/05/08)
IF: 28.200- 作者:Jing Zhang, Sunmin Lim, Mira Yu
- 期刊: Cancer Discovery
- DOI:10.1158/2159-8290.CD-24-0006
- 引用产品: CL-0225
-
D3S-001, a KRAS G12C inhibitor with rapid target engagement kinetics, overcomes nucleotide cycling and demonstrates robust preclinical and clinical activities (2024/05/08)
IF: 28.200- 作者:Jing Zhang, Sunmin Lim, Mira Yu
- 期刊: Cancer Discovery
- DOI:10.1158/2159-8290.CD-24-0006
- 引用产品: CL-0223
-
D3S-001, a KRAS G12C inhibitor with rapid target engagement kinetics, overcomes nucleotide cycling and demonstrates robust preclinical and clinical activities (2024/05/08)
IF: 28.200- 作者:Jing Zhang, Sunmin Lim, Mira Yu
- 期刊: Cancer Discovery
- DOI:10.1158/2159-8290.CD-24-0006
- 引用产品: CL-0016
首页 上一页 45678910111213 下一页 末页 合计1410页 合计11273条记录 |